FDA Advisory Committee Recommends Approval of Regeneron and Sanofi's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. NVDA
3. ONON
4. PSKY
5. META
6. VRTX
7. LGND
8. MA
9. ACN
10. IAUX

Go back to FDA Advisory Committee Recommends Approval of Regeneron and Sanofi's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia
Regeneron (NASDAQ: REGN) Delayed: 792.77 -5.4 (0.68%)
Previous Close $798.17    52 Week High $592.36 
Open $802.48    52 Week Low $325.35 
Day High $803.99    P/E 208.08 
Day Low $792.07    EPS $3.81 
Volume 34,205       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.58 -0.04 (0.27%)
Previous Close $14.62    52 Week High $5.58 
Open $14.68    52 Week Low $3.60 
Day High $14.71    P/E N/A 
Day Low $14.55    EPS $0.00 
Volume 1,022,909       

SANOFI (NASDAQ: SNY) Delayed: 42.12 -0.38 (0.89%)
Previous Close $42.50    52 Week High $44.76 
Open $42.34    52 Week Low $36.81 
Day High $42.38    P/E N/A 
Day Low $42.03    EPS $0.00 
Volume 457,560